Co-infection of ST2IP carbapenem-resistant Acinetobacter baumannii with SARS-CoV-2 in the patients admitted to a Tehran tertiary referral hospital
- PMID: 34496774
- PMCID: PMC8423834
- DOI: 10.1186/s12879-021-06642-2
Co-infection of ST2IP carbapenem-resistant Acinetobacter baumannii with SARS-CoV-2 in the patients admitted to a Tehran tertiary referral hospital
Abstract
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is among the most concerning cause of healthcare-associated infections (HAI) due to its high level of antibiotic resistance and high mortality. In the era of the COVID-19 pandemic, the key priority of infection control committees is to contain the dissemination of antibiotic resistant Gram-negative bacteria. Here, we aimed to timely recognize the emergence of CRAB in COVID-19 cases admitted to the wards of a tertiary referral hospital and to identify the genetic relatedness of the isolates.
Methods: From 30 March to 30 May 2020, a total of 242 clinical samples from COVID-19 cases were screened for CRAB isolates using standard microbiologic and antibiotic susceptibility tests. The PCRs targeting oxa23, oxa24, oxa58, blaTEM and blaNDM-1 genes were performed. Two multiplex PCRs for identifying the global clones (GC) of A. baumannii were also performed. The sequence type of CRABs was determined using Institut Pasteur (IP) multilocus sequence typing (MLST) scheme.
Results: Eighteen CRAB isolates were recovered from COVID-19 patients with the mean age of 63.94 ± 13.8 years. All but 4 COVID-19 patients co-infected with CRAB were suffering from an underlying disease. Death was recorded as the outcome in ICUs for 9 (50%) COVID-19 patients co-infected with CRAB. The CRAB isolates belong to GC2 and ST2IP and carried the oxa23 carbapenem resistance gene.
Conclusion: This study demonstrated the co-infection of CRAB isolates and SARS-CoV-2 in the patients admitted to different ICUs at a referral hospital in Tehran. The CRAB isolates were found to belong to ST2IP, share the oxa23 gene and to have caused several outbreaks in the wards admitting COVID-19 patients.
Keywords: COVID-19; Carbapenem-resistant Acinetobacter baumannii (CRAB); SARS-CoV-2; Sequence type; oxa23; oxa24; oxa58.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Lineage 2, Global Clone 1, from Outbreaks in 2012-2013 at a Tehran Burns Hospital.mSphere. 2020 Apr 8;5(2):e00164-20. doi: 10.1128/mSphere.00164-20. mSphere. 2020. PMID: 32269158 Free PMC article.
-
A single-center analysis of clonal transmission of carbapenem-resistant Acinetobacter baumannii among intensive care unit patients during the COVID-19 pandemic.Sci Rep. 2024 Oct 29;14(1):25897. doi: 10.1038/s41598-024-77238-4. Sci Rep. 2024. PMID: 39468199 Free PMC article.
-
The context of blaOXA-23 gene in Iraqi carbapenem-resistant Acinetobacter baumannii isolates belonging to global clone 1 and global clone 2.BMC Res Notes. 2024 Oct 8;17(1):300. doi: 10.1186/s13104-024-06890-w. BMC Res Notes. 2024. PMID: 39380025 Free PMC article.
-
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).Future Microbiol. 2017 Jul;12:801-815. doi: 10.2217/fmb-2016-0200. Epub 2017 Jun 12. Future Microbiol. 2017. PMID: 28604100 Review.
-
Prevalence and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii: A Comprehensive Systematic Review of Cross-Sectional Studies from Iran.Microb Drug Resist. 2020 Mar;26(3):270-283. doi: 10.1089/mdr.2018.0435. Epub 2019 May 24. Microb Drug Resist. 2020. PMID: 30822197
Cited by
-
Occurrence of Acinetobacter baumannii genomic resistance islands (AbGRIs) in Acinetobacter baumannii strains belonging to global clone 2 obtained from COVID-19 patients.BMC Microbiol. 2023 Aug 24;23(1):234. doi: 10.1186/s12866-023-02961-3. BMC Microbiol. 2023. PMID: 37620750 Free PMC article.
-
Genomic Comparative Analysis of Two Multi-Drug Resistance (MDR) Acinetobacter baumannii Clinical Strains Assigned to International Clonal Lineage II Recovered Pre- and Post-COVID-19 Pandemic.Biology (Basel). 2023 Feb 24;12(3):358. doi: 10.3390/biology12030358. Biology (Basel). 2023. PMID: 36979049 Free PMC article.
-
Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.Eur J Clin Microbiol Infect Dis. 2023 Dec;42(12):1405-1423. doi: 10.1007/s10096-023-04677-8. Epub 2023 Oct 28. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37897520 Free PMC article. Review.
-
The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens.Front Cell Infect Microbiol. 2022 Mar 17;12:823626. doi: 10.3389/fcimb.2022.823626. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372126 Free PMC article. Review.
-
Virulence potential of multidrug-resistant Acinetobacter baumannii isolates from COVID-19 patients on mechanical ventilation: The first report from Serbia.Front Microbiol. 2023 Feb 6;14:1094184. doi: 10.3389/fmicb.2023.1094184. eCollection 2023. Front Microbiol. 2023. PMID: 36825087 Free PMC article.
References
-
- Wieland K, Chhatwal P, Vonberg R-P. Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: results of a systematic review. N Engl J Med. 2018;46(6):643–648. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous